FindTrial
Sign In

Probiotics promoting negative conversion in persistent SARS-CoV-2-positive patients: a randomized controlled trial

Probiotics promoting negative conversion in persistent SARS-CoV-2-positive patients: a randomized controlled trial

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2200060067
Enrollment
Unknown
Registered
2022-05-17
Start date
2022-05-16
Completion date
Unknown
Last updated
2024-04-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Novel Coronavirus Pneumonia (COVID-19)

Interventions

Experimental group:Probiotics
Control group:None

Sponsors

Xijing Hospital, the Fourth Military Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
16 Years to 70 Years

Inclusion criteria

Inclusion criteria: 1. Aged 16-70 years; 2. Patients who have positive nucleic acid and have not turned negative for 6 consecutive days.

Exclusion criteria

Exclusion criteria: 1. Patients who have received probiotic treatment in the last 1 month; 2. Have taken antibiotics in the past week; 3. Pregnant or lactating patients; 4. Unwilling to participate in this experiment.

Design outcomes

Primary

MeasureTime frame
Nucleic acid-negative conversion time;—

Secondary

MeasureTime frame
Remission of symptoms;Duration of symptoms;Progression;—

Countries

China

Contacts

Public ContactSun Shiren

Xijing Hospital, the Fourth Military Medical University

sunsrsun@163.com+86 13679220706

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026